Aclaris, Biosion in Global License Agreement for Biologics Assets

 - Enhances Aclaris’ pipeline with complementary biologics portfolio -

- Expands leadership team with addition of seasoned biotech executives -
- Management to host conference call today at 8:30 AM ET -

Conference Call and Webcast

Management will conduct a conference call at 8:30 AM ET today to discuss the Biosion transaction and a corporate update. To access the live webcast of the call and the accompanying slide presentation, please visit the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

https://www.globenewswire.com/news-release/2024/11/18/2982759/37216/en/Aclaris-Therapeutics-Announces-Exclusive-Global-License-Agreement-with-Biosion-Inc-adding-Potential-Best-in-Class-Biologics-Assets-to-Pipeline.html